quinoxalines has been researched along with Ototoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; He, Y; Hu, B; Li, W; Nie, G; Tang, D; Zhao, L; Zheng, Z | 1 |
| Hati, S; Hausman, W; He, DZ; Liu, H; Xu, Z; Zallocchi, M; Zuo, J | 1 |
2 other study(ies) available for quinoxalines and Ototoxicity
| Article | Year |
|---|---|
Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity.
Topics: Animals; Cell Line; Hair Cells, Auditory; Mice; Neomycin; Ototoxicity; Quinoxalines; Reactive Oxygen Species; Spiro Compounds | 2020 |
Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss.
Topics: Animals; Cell Death; Cells, Cultured; Fibroblasts; Hearing Loss; Mice; Ototoxicity; Protective Agents; Quinoxalines; Zebrafish | 2021 |